Mesothelioma vs. Lung Cancer: What’s the Difference?

Mesothelioma and lung cancer both involve the chest. They can cause similar symptoms, and asbestos always seems to come up in conversations about both. It is easy to assume they’re basically the same problem with different names.

They are not.

The simplest way to put it is this: Mesothelioma starts in the lining around the lung. Lung cancer starts in the lung itself. That one detail changes the tests we rely on, the treatments we consider, and often the specialist input you need.

Let’s talk through it properly.

While both can cause breathlessness and chest pain, pleural mesothelioma is a totally different kind of cancer. Both can show up as “something in the chest” on imaging. But the diseases behave differently, and we treat them differently. To make certain if you do have one or the other or none at all, it’s always best to consult an oncology specialist to ensure you receive the most accurate diagnosis and a treatment plan tailored specifically to your condition.

Where each cancer starts

Mesothelioma: the lining

Your lungs sit inside the chest, wrapped in a very thin membrane called the pleura. It helps the lungs move smoothly as you breathe. Mesothelioma usually develops in that lining.

That is why mesothelioma often shows up as:

• thickening of the pleura
• fluid collecting around the lung (a pleural effusion)
• a feeling of tightness or heaviness on one side

Lung cancer: the lung itself

Lung cancer begins within the lung. It may arise in the airways or deeper in the lung tissue. Depending on where it starts, it can affect breathing, cause a persistent cough, or irritate airways and blood vessels.

Causes and risk factors: where asbestos fits in

This is the bit that gets confused most.

Mesothelioma and asbestos

Mesothelioma is strongly associated with asbestos exposure. Not everyone with mesothelioma has a clear exposure history, but asbestos is the key risk factor we think about.

Perhaps the most frustrating aspect is timing. Mesothelioma can develop decades after exposure. People may have worked around asbestos in their twenties and only develop symptoms later in life.

Lung cancer and smoking (and other causes)

Lung cancer has several risk factors, but smoking remains the biggest one overall.

Other recognised risks include:

• second-hand smoke
• radon
• air pollution
• certain workplace exposures (including asbestos)
• previous radiotherapy to the chest in some cases

Asbestos can increase lung cancer risk, particularly when combined with smoking. But it is important to be clear: Most lung cancers are not mesothelioma, and most are not primarily caused by asbestos.

Also, exposure history is useful, but it is not a diagnosis. We do not guess. We confirm.

Types: how they are classified

Mesothelioma subtypes

Mesothelioma is usually described by the way the cells look under the microscope. You may hear terms like:

• epithelioid
• sarcomatoid
• biphasic (a mix)

Subtype matters because it can influence prognosis and which treatments are most realistic.

Lung cancer types

Lung cancer is broadly split into:

• Non-small cell lung cancer (NSCLC), which includes adenocarcinoma and squamous cell carcinoma
• Small cell lung cancer (SCLC) tends to grow and spread more quickly

For NSCLC, modern care also depends heavily on whether the tumour has certain molecular features. That is why you will often hear about “molecular testing” or “genomics”.

Symptoms: why do they overlap so much?

Both mesothelioma and lung cancer can cause very similar symptoms, which is part of what makes the whole thing so confusing. People may notice breathlessness, chest discomfort or pain, a cough that does not settle, fatigue, weight loss, or a reduced appetite.

There are a few features that can sometimes point us in a direction, but they are not reliable on their own.

Mesothelioma is more likely to involve fluid around the lung that drives breathlessness, pleural thickening or restriction that causes a dull, dragging ache, and symptoms that feel a bit more one-sided in the chest.

Lung cancer is more likely to involve coughing up blood, a new persistent cough or a clear change in a longstanding cough, and in some cases, hoarseness, wheeze, or recurrent chest infections.

But none of this is definitive. I mean, plenty of people with lung cancer never cough up blood. Plenty of people with mesothelioma present with vague breathlessness. We cannot just eyeball it and give you a diagnosis. That’s why tests and scans are important.

How doctors tell the difference

If you take one thing away, make it this: The diagnosis comes from tissue and specialist pathology.

Step 1: History and examination

We ask about symptoms, timing, weight changes, and risk factors like smoking and asbestos exposure. This helps frame the problem, but it does not confirm what it is.

Step 2: Imaging

Common tests include:

• Chest X-ray
• CT scan of the chest
• PET-CT, in many cases, when we are staging or clarifying activity

Imaging can suggest patterns. For example, pleural thickening and fluid may suggest a pleural process. A mass within lung tissue may suggest lung cancer. But imaging alone cannot always separate the two.

Step 3: Sampling and biopsy

This is where clarity usually comes from. Depending on what we see, we may use:

• drainage of pleural fluid, sometimes with tests on the fluid
• needle biopsy
• a camera test into the chest (thoracoscopy) to obtain better samples

Small samples can be tricky. Sometimes we need a more substantial biopsy because the distinction matters very much.

Step 4: Specialist pathology testing

Under the microscope, some cancers can look similar. To get it right, pathologists use panels of tests on the tissue.

These include immunohistochemistry, which uses markers to indicate what sort of cells the tumour resembles. In some centres and scenarios, additional molecular approaches can support the diagnosis. Research has shown that DNA methylation patterns can help distinguish pleural mesothelioma from certain lung cancers, such as lung adenocarcinoma, with very high accuracy.

That last point is not something most people need to think about day to day. It is simply reassurance that when cases are borderline, we do have sophisticated tools to reduce uncertainty.

And yes, when there is any doubt, a second pathology opinion can be sensible. It is not dramatic. It is just good medicine.

Staging: what it means and why it matters

“Stage” is a way of describing how far a cancer has spread. It influences treatment choices and aims.

Mesothelioma staging

Mesothelioma staging focuses on how much of the pleura is involved, whether nearby structures are affected (diaphragm, chest wall, lung), lymph node involvement, and whether there is spread beyond the chest

Lung cancer staging

Lung cancer staging looks at the size and location of the tumour in the lung, lymph node involvement (often in the centre of the chest), and distant spread (commonly to the brain, bone, liver, and adrenal glands).

Two people can have “stage 4” disease and have very different experiences, depending on tumour biology, symptoms, and how well treatments work. So staging is useful, but it is not the whole story.

Treatment: where they overlap and where they diverge

Treatment is usually planned by a multidisciplinary team. That means surgeons, oncologists, radiologists, respiratory physicians, specialist nurses, and pathologists discussing the case together.

Mesothelioma treatment options

Depending on stage, subtype, and fitness, treatments may include:

• systemic therapy (often chemotherapy-based regimens, and in some settings immunotherapy)
• surgery for selected patients as part of a specialist approach
• radiotherapy in certain circumstances, including symptom control or as part of a wider plan
• symptom-focused treatments, such as managing pleural fluid and breathlessness

The big theme is selection and specialisation. Because mesothelioma is uncommon, outcomes tend to be better when decisions are made by teams that see it regularly.

Lung cancer treatment options

Treatment depends heavily on type (NSCLC vs SCLC), stage, and molecular profile.

Options may include:

• surgery for early-stage disease in appropriate patients
• radiotherapy, including highly targeted approaches for selected early-stage tumours
• chemotherapy
• immunotherapy
• targeted therapies for cancers with certain molecular changes, which can be genuinely game-changing for the right person

Even when a cure is not possible, treatment can still slow things down and improve symptoms. It is not always about “nothing to do” versus “something to do”. There is a lot of middle ground.

What is the prognosis?

People understandably want numbers. It is also where online information can do the most harm.

Prognosis depends on:

• stage at diagnosis
• tumour subtype and biology
• overall health and fitness
• how well the cancer responds to treatment
• complications like fluid, infection, or weight loss

Broadly, earlier-stage disease tends to do better than advanced disease in both conditions. But averages are not you. They are just averages.

If you want a realistic picture, the best question is usually: “Based on my stage and my type, what are the goals of treatment, and what are the likely next steps over the next few months?” That gets you something practical rather than a frightening statistic.

What should you do next?

If you are worried, a few grounded steps can help you feel less at the mercy of guesswork. First, make sure there is a tissue diagnosis. Scans can suggest what is going on, but biopsies confirm it. It is also worth asking who reviewed the pathology, because when the distinction between mesothelioma and lung cancer is difficult, specialist thoracic pathology input can be important.

You can then check whether your case has been discussed in an MDT, which is standard in cancer care and helps ensure nothing obvious is missed. Ask what the plan is for staging as well. That often means a CT scan and sometimes a PET-CT, with additional tests depending on symptoms. And do not ignore worsening breathlessness, chest pain, or coughing up blood. These symptoms need prompt medical assessment, whatever the underlying cause.

About Dr James Wilson

Dr James Wilson is a consultant oncologist with a focus on lung cancer and advanced radiotherapy. Based in Central London, he works exclusively in private practice, helping patients move quickly from uncertainty to a clear diagnosis and treatment plan, with steady, practical support when time matters.